Trillium Therapeutics Inc... (TRIL)
NASDAQ: TRIL
· Real-Time Price · USD
18.44
0.00 (0.00%)
At close: Apr 24, 2025, 3:47 PM
Trillium Therapeutics Revenue
Trillium Therapeutics reported an annual revenue of $148K, reflecting a 19.35% growth. For the quarter ending September 30, 2021, Trillium Therapeutics generated $0 in revenue.
Revenue (ttm)
148K
Revenue Growth
19.35%
Price / Sales Ratio
8324.29
Revenue / Employee
4.48K
Employees
33
Market Cap
0
Revenue Chart
Revenue History
Fiscal Year End | Revenue | % Change |
---|---|---|
Dec 31, 2020 | 148K | +19.35% |
Dec 31, 2019 | 124K | +Infinity% |
Dec 31, 2018 | 0 | n/a |
Dec 31, 2017 | 0 | n/a |
Dec 31, 2016 | 0 | n/a |
Dec 31, 2015 | 0 | n/a |
Dec 31, 2014 | 0 | n/a |
Dec 31, 2013 | 0 | n/a |
Dec 31, 2012 | 0 | n/a |
Dec 31, 2011 | 0 | n/a |
Dec 31, 2010 | 0 | n/a |
Dec 31, 2009 | 0 | n/a |
Dec 31, 2008 | 0 | n/a |
Dec 31, 2007 | 0 | n/a |
Dec 31, 2006 | 0 | n/a |
Dec 31, 2005 | 0 | n/a |
Dec 31, 2004 | 0 | n/a |